IPC The Hospitalist Company, Inc. Reaffirms Guidanc...( NORTH HOLLYWOOD Calif. June 17 /-...)

NORTH HOLLYWOOD, Calif., June 17 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice, today reaffirmed its guidance for full year 2008 revenue to be in the range of $239 million to $245 million and full year 2008 earnings per adjusted pro-forma fully diluted share (excluding bonuses incurred in the first quarter related to the Company's IPO) to be in the range of $0.87 to $0.94. Absent the impact of acquisitions, the Company typically experiences a pattern of seasonality with net revenue and earnings in the first and fourth quarters of the year higher than those in the second and third quarters. The Company expects this pattern to continue and believes it is primarily due to the following factors:

-- the number of physicians the Company has on staff during the quarter,

which may fluctuate based upon the timing of hires caused by the end of

the academic year for graduating resident physicians and the schedule

of the Internal Medicine Board exams and terminations in our existing

practices; and

-- fluctuations in patient encounters which are impacted by hospital

census and physician productivity and often reflect seasonality due to

the higher occurrence of such illnesses as flu and pneumonia in patient

populations in the first quarter.

This guidance does not include new market acquisitions. The Company undertakes no obligation following the date of this press release to update or revise any such statements or projections whether as a result of new information, future events, or otherwise.

Reconciliation for Non-GAAP Financial Measures

The Company's Board of Dir
'/>"/>